The role of A-kinase interacting protein 1 in regulating progression and stemness as well as indicating the prognosis in glioblastoma

por Tang, Jingxia, Peng, Shirong, Yan, Haifeng, Ni, Ming, Hou, Xiaodan, Ma, Peizhi, Li, Yuanlong
Publicado 2022

SYTL2 promotes metastasis of prostate cancer cells by enhancing FSCN1-mediated pseudopodia formation and invasion

por Li, Zean, Tao, Yiran, Gao, Ze, Peng, Shirong, Lai, Yiming, Li, Kaiwen, Chen, Xu, Huang, Hai
Publicado 2023

Glutathione-sensitive nanoparticles enhance the combined therapeutic effect of checkpoint kinase 1 inhibitor and cisplatin in prostate cancer

por Peng, Shirong, Zhang, Xinyu, Huang, Hao, Cheng, Bisheng, Xiong, Zhi, Du, Tao, Wu, Jun, Huang, Hai
Publicado 2022

GADD45B Is a Potential Diagnostic and Therapeutic Target Gene in Chemotherapy-Resistant Prostate Cancer

por Wang, Qiong, Wu, Wanhua, Gao, Ze, Li, Kaiwen, Peng, Shirong, Fan, Huiyang, Xie, Zhongqiu, Guo, Zhenghui, Huang, Hai
Publicado 2021

Immune Cytolytic Activity as an Indicator of Immune Checkpoint Inhibitors Treatment for Prostate Cancer

por Gao, Ze, Tao, Yiran, Lai, Yiming, Wang, Qiong, Li, Zean, Peng, Shirong, Chen, Junxiu, Cai, Wenli, Li, Kaiwen, Huang, Hai
Publicado 2020

Immune Signatures Combined With BRCA1-Associated Protein 1 Mutations Predict Prognosis and Immunotherapy Efficacy in Clear Cell Renal Cell Carcinoma

por Gao, Ze, Chen, Junxiu, Tao, Yiran, Wang, Qiong, Peng, Shirong, Yu, Shunli, Zeng, Jianwen, Li, Kaiwen, Xie, Zhongqiu, Huang, Hai
Publicado 2021

B7 score and T cell infiltration stratify immune status in prostate cancer

por Zhou, Qianghua, Li, Kaiwen, Lai, Yiming, Yao, Kai, Wang, Qiong, Zhan, Xiangyu, Peng, Shirong, Cai, Wenli, Yao, Wei, Zang, Xingxing, Xu, Kewei, Huang, Jian, Huang, Hai
Publicado 2021

Loss of NEIL3 activates radiotherapy resistance in the progression of prostate cancer

por Wang, Qiong, Li, Zean, Yang, Jin, Peng, Shirong, Zhou, Qianghua, Yao, Kai, Cai, Wenli, Xie, Zhongqiu, Qin, Fujun, Li, Hui, Chen, Xu, Li, Kaiwen, Huang, Hai
Publicado 2022

Topoisomerase II-binding protein 1 promotes the progression of prostate cancer via ATR-CHK1 signaling pathway

por Li, Kaiwen, Peng, Shirong, Li, Zean, Lai, Yiming, Wang, Qiong, Tao, Yiran, Wu, Wanhua, Zhou, Qianghua, Gao, Ze, Chen, Junxiu, Li, Hui, Cai, Wenli, Guo, Zhenghui, Huang, Hai
Publicado 2020

The metastatic promoter DEPDC1B induces epithelial‐mesenchymal transition and promotes prostate cancer cell proliferation via Rac1‐PAK1 signaling

por Li, Zean, Wang, Qiong, Peng, Shirong, Yao, Kai, Chen, Junxiu, Tao, Yiran, Gao, Ze, Wang, Fen, Li, Hui, Cai, Wenli, Lai, Yiming, Li, Kaiwen, Chen, Xu, Huang, Hai
Publicado 2020